We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMBT
14801
DELISTED
Pivotal Holdings Corp Class A Ordinary Share
GMBT
-94,303
Closed -$885K
GMBTW
14802
DELISTED
Pivotal Holdings Corp Warrant
GMBTW
-31,318
Closed -$21K
LEVL
14803
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
-125,978
Closed -$5.03M
LAIX
14804
DELISTED
LAIX Inc. American Depositary Shares, each representing fourteen Class A Ordinary Shares
LAIX
-13,073
Closed -$52K
NEW
14805
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
-26,412
Closed -$55K
WEI
14806
DELISTED
Weidai Ltd. American depositary shares, each representing five (5) Class A ordinary shares
WEI
-14,655
Closed -$16K
SBM
14807
DELISTED
ProShares Short Basic Materials
SBM
-6,966
Closed -$307K
AVEO
14808
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-11,900
Closed -$67K
CFRX
14809
DELISTED
ContraFect Corporation
CFRX
-186
Closed -$52.5K
SRAX
14810
PUT
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
-10,000
Closed -$48K
GNCA
14811
CALL
DELISTED
Genocea Biosciences, Inc.
GNCA
-12,000
Closed -$15K
GNCA
14812
DELISTED
Genocea Biosciences, Inc.
GNCA
-1,843,112
Closed -$2.3M
VISL
14813
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-3,085
Closed -$46.4K
ADRE
14814
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
-30,667
Closed -$1.35M
CEI
14815
DELISTED
Camber Energy, Inc
CEI
-757
Closed -$25.9K
MACK
14816
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-11,300
Closed -$71K
COWN
14817
PUT
DELISTED
Cowen Inc. Class A Common Stock
COWN
-22,900
Closed -$621K
IO
14818
CALL
DELISTED
ION Geophysical Corporation
IO
-30,400
Closed -$27K
IO
14819
DELISTED
ION Geophysical Corporation
IO
-50,699
Closed -$44K
IO
14820
PUT
DELISTED
ION Geophysical Corporation
IO
-47,000
Closed -$41K
AILEW
14821
DELISTED
iLearningEngines, Inc. Warrant
AILEW
-625,000
Closed -$183K
PLAOU
14822
DELISTED
Patria Latin American Opportunity Acquisition Corp. Unit
PLAOU
-650,000
Closed -$6.53M
CHIX
14823
PUT
DELISTED
Global X MSCI China Financials ETF
CHIX
-15,000
Closed -$208K
BRD.WS
14824
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
-301,000
Closed -$96K
UBA
14825
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
-11,114
Closed -$192K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.